209 related articles for article (PubMed ID: 31745757)
1. Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China.
Fang XB; Xie MS; Song ZB; Zhong ZG; Wang Y; Ou ZL; Dang C; Li L; Zhang WX
Neurol Sci; 2020 Mar; 41(3):645-652. PubMed ID: 31745757
[TBL] [Abstract][Full Text] [Related]
2. Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
Jochim A; Meindl T; Huber C; Mantel T; Zwirner S; Castrop F; Haslinger B
J Neurol; 2020 Jan; 267(1):267-275. PubMed ID: 31630241
[TBL] [Abstract][Full Text] [Related]
3. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
5. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
[TBL] [Abstract][Full Text] [Related]
6. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Cardoso F
Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin in Meige's syndrome: A video-based case series.
Pandey S; Sharma S
Neurol India; 2018; 66(1):71-76. PubMed ID: 29322963
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
10. Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm.
Namiguchi K; Mizoue S; Ohta K; Shiraishi A
Curr Eye Res; 2018 Jul; 43(7):896-901. PubMed ID: 29641935
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of botulinum toxin type a after topical anesthesia.
Sami MS; Soparkar CN; Patrinely JR; Hollier LM; Hollier LH
Ophthalmic Plast Reconstr Surg; 2006; 22(6):448-52. PubMed ID: 17117100
[TBL] [Abstract][Full Text] [Related]
12. High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?
Boyle MH; McGwin G; Flanagan CE; Vicinanzo MG; Long JA
Ophthalmic Plast Reconstr Surg; 2009; 25(2):81-4. PubMed ID: 19300145
[TBL] [Abstract][Full Text] [Related]
13. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin a in the treatment of blepharospasm: a 10-year experience.
Silveira-Moriyama L; Gonçalves LR; Chien HF; Barbosa ER
Arq Neuropsiquiatr; 2005 Jun; 63(2A):221-4. PubMed ID: 16100966
[TBL] [Abstract][Full Text] [Related]
15. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
Vargel I; Canter HI; Topaloglu H; Erk Y
J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
[TBL] [Abstract][Full Text] [Related]
16. Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.
Lee S; Park S; Lew H
Korean J Ophthalmol; 2018 Feb; 32(1):1-7. PubMed ID: 29376224
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin injection and tear production.
Alsuhaibani AH; Eid SA
Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
[TBL] [Abstract][Full Text] [Related]
18. Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm.
Sacramento DRC; Lima A; Maia DP; Cunningham M; Maciel RH; Camargos ST; Cardoso F
Mov Disord; 2019 Sep; 34(9):1401-1403. PubMed ID: 31251420
[No Abstract] [Full Text] [Related]
19. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
Burbaud P; Arnaud A; Burbaud A; Lagueny A
J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
[TBL] [Abstract][Full Text] [Related]
20. Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection.
Casse G; Adenis JP; Sauvage JP; Robert PY
Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1307-14. PubMed ID: 18581129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
